Discovery of potent and efficacious pyrrolopyridazines as dual JAK1/3 inhibitors.

Publication

Citation
Hynes J, Wu H, Kempson J, Duan JJ, Lu Z, Jiang B, Stachura S, Tokarski JS, Sack JS, Khan JA, Lippy JS, Zhang RF, Pitt S, Shen G, Gillooly K, McIntyre K, Carter PH, Barrish JC, Nadler SG, Salter-Cid LM, Fura A, Schieven GL, Pitts WJ, Wrobleski ST.: Discovery of potent and efficacious pyrrolopyridazines as dual JAK1/3 inhibitors. Bioorg Med Chem Lett, Volume 27 (14), 2017
Authors
Barrish JC, Carter PH, Duan JJ, Fura A, Gillooly K, Hynes J, Jiang B, Kempson J, Khan JA, Lippy JS, Lu Z, McIntyre K, Nadler SG, Pitt S, Pitts WJ, Sack JS, Salter-Cid LM, Schieven GL, Shen G, Stachura S, Tokarski JS, Wrobleski ST., Wu H, Zhang RF
Journal
Bioorg Med Chem Lett
Year
2017
PubMed
28539220
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc
Discovery of potent and efficacious pyrrolopyridazines as dual JAK1/3 inhibitors. | MolMeDB